| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $17.6B | $16.4B | $16.0B | $15.4B | $13.4B | $10.8B | $11.1B | $10.6B |
| Cost of Revenue | $12.0B | $11.1B | $10.8B | $10.5B | $9.0B | $7.4B | $7.6B | $7.4B |
| Gross Profit | — | — | — | — | — | — | — | — |
| R&D Expense | $0.8B | $1.2B | $1.3B | $1.1B | $1.1B | $0.9B | $0.8B | $0.8B |
| SG&A Expense | — | — | — | — | — | — | — | — |
| Operating Income | $2.0B | $2.4B | $1.9B | $2.3B | $2.0B | $1.5B | $1.6B | $1.5B |
| Net Income | $1.4B | $1.7B | $1.4B | $1.7B | $1.4B | $1.3B | $1.1B | $1.0B |
| EPS (Basic) | $2.27 | $2.69 | $2.18 | $2.63 | $2.24 | $2.03 | $1.77 | $1.61 |
| EPS (Diluted) | $2.25 | $2.66 | $2.15 | $2.60 | $2.20 | $1.99 | $1.74 | $1.58 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $65.4B | $55.9B | $51.2B | $47.3B | $43.2B | $37.1B | $29.8B | $24.4B |
| Current Assets | $28.9B | $20.9B | $23.4B | $21.6B | $19.7B | $17.7B | $15.5B | $13.6B |
| Cash & Equivalents | $11.5B | $5.0B | $9.0B | $7.9B | $8.2B | $8.4B | $6.1B | $5.1B |
| Total Liabilities | — | — | — | — | — | — | — | — |
| Current Liabilities | $20.4B | $19.0B | $18.0B | $17.5B | $15.7B | $12.7B | $11.1B | $10.2B |
| Stockholders' Equity | $31.2B | $28.3B | $25.7B | $22.1B | $19.5B | $17.0B | $14.4B | $10.4B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $11.5B | $9.1B | $9.5B | $9.5B | $9.0B | $8.2B | $6.6B | $6.0B |
| Investing Cash Flow | $-2.0B | $-7.1B | $-2.6B | $-4.3B | $-4.3B | $-1.9B | $-1.8B | $-1.2B |
| Capital Expenditures | $0.6B | $0.5B | $0.5B | $0.7B | $0.6B | $0.6B | $0.6B | $0.6B |
| Financing Cash Flow | $-2.9B | $-6.1B | $-5.6B | $-5.3B | $-4.9B | $-4.0B | $-3.8B | $-3.7B |